B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

IL3

MOLECULAR TARGET

interleukin 3

UniProt: P08700NCBI Gene: 35621 compounds

IL3 (interleukin 3) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting IL3

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Afatinib0.691

About IL3 as a Drug Target

IL3 (interleukin 3) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented IL3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

IL3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.